MTS: ICYMI

ICYMI: Lilly Leverages Digital Diabetes Devices

ICYMI: Lilly Leverages Digital Diabetes Devices

Competitors in the diabetes market are working to meet consumer demand for more digitally integrated and interconnected diabetes management solutions, and collaborations among the various participants represent the new norm in this industry. In this ICYMI, Big pharma Eli Lilly partners with medtech to shift its diabetes focus from molecules to outcomes.